StockClub

ACRS

ACRSAclaris Therapeutics, Inc.$ --
Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc.

ACRS

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
1M USD
YoY -85.9%
Operating Income
-23M USD
YoY +77.2%
Net Income
-20M USD
YoY +79.5%
EPS
-0.16$
YoY +84.2%

Revenue

$7.8M
FY2024 Q1$2.4M
$2.4M
Q1
FY2024 Q2$5.2M
$5.2M
Q2
FY2024 Q3$9.5M
$9.5M
Q3
FY2024 Q4$18.7M
$18.7M
Q4
FY2025 Q1$1.5M
$1.5M
Q1
FY2025 Q2$3.2M
$3.2M
Q2
FY2025 Q3$6.5M
$6.5M
Q3
FY2025 Q4$7.8M
$7.8M
Q4
Actual
$-10.9M (-58.2%)

Net Income

$-64.9M
FY2024 Q1$-16.9M
$-16.9M
Q1
FY2024 Q2$-27.9M
$-27.9M
Q2
FY2024 Q3$-35.5M
$-35.5M
Q3
FY2024 Q4$-132.1M
$-132.1M
Q4
FY2025 Q1$-15.1M
$-15.1M
Q1
FY2025 Q2$-30.5M
$-30.5M
Q2
FY2025 Q3$-45.1M
$-45.1M
Q3
FY2025 Q4$-64.9M
$-64.9M
Q4
Actual
+$67.1M (+50.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$6.5M
Est:$6.3M
FY2020BEAT
$6.5M
FY2021MISS
Actual:$6.8M
Est:$7.1M
FY2021MISS
$6.8M
FY2022BEAT
Actual:$29.8M
Est:$24M
FY2022BEAT
$29.8M
FY2023MISS
Actual:$31.2M
Est:$32M
FY2023MISS
$31.2M
FY2024BEAT
Actual:$18.7M
Est:$11.6M
FY2024BEAT
$18.7M
FY2025MISS
Actual:$7.8M
Est:$8.8M
FY2025MISS
$7.8M

Analyst Estimates